IMPACT BIOMEDICAL INC. financial data

Symbol
IBO on NYSE
Location
Houston, TX
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 11 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 8.6% % -46%
Quick Ratio 2.6% %
Debt-to-equity -1204% %
Return On Equity -772% % -644%
Return On Assets -63% % 0.32%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 107,821,231 shares 792%
Common Stock, Shares, Outstanding 104,621,231 shares 809%
Entity Public Float $7,599,000 USD
Common Stock, Value, Issued $105,000 USD 855%
Weighted Average Number of Shares Outstanding, Basic 31,550,457 shares 193%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $18,000 USD
Research and Development Expense $340,000 USD 22%
Selling and Marketing Expense $24,000 USD -96%
Operating Income (Loss) $4,282,000 USD 85%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $14,450,000 USD 42%
Net Income (Loss) Attributable to Parent $11,838,000 USD 52%
Earnings Per Share, Basic -0.38 USD/shares 83%
Earnings Per Share, Diluted -0.38 USD/shares 83%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,000 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current $5,000 USD
Inventory, Net $63,000 USD
Assets, Current $411,000 USD -83%
Property, Plant and Equipment, Net $13,000 USD -95%
Goodwill $25,093,000 USD 0%
Assets $17,405,000 USD -14%
Accounts Payable, Current $347,000 USD 11%
Accrued Liabilities, Current $194,000 USD 0%
Liabilities, Current $1,162,000 USD -88%
Deferred Income Tax Liabilities, Net $688,000 USD -79%
Liabilities $1,850,000 USD -86%
Retained Earnings (Accumulated Deficit) $49,507,000 USD -31%
Stockholders' Equity Attributable to Parent $12,609,000 USD 196%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $15,555,000 USD 115%
Liabilities and Equity $17,405,000 USD -14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $682,000 USD -41%
Net Cash Provided by (Used in) Financing Activities $483,000 USD -53%
Net Cash Provided by (Used in) Investing Activities $1,000 USD
Common Stock, Shares Authorized 4,000,000,000 shares 0%
Common Stock, Shares, Issued 104,621,231 shares 809%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $681,000 USD -68200%
Deferred Tax Assets, Gross $5,430,000 USD 23%
Depreciation $1,000 USD -50%
Property, Plant and Equipment, Gross $30,000 USD -90%
Deferred Tax Assets, Operating Loss Carryforwards $4,344,000 USD 47%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Additional Paid in Capital $62,011,000 USD 48%
Preferred Stock, Shares Outstanding 0 shares -100%
Amortization of Intangible Assets $282,000 USD 1.4%
Depreciation, Depletion and Amortization $283,000 USD 1.1%
Interest Expense $793,000 USD -26%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%